Fundraising Fox3E Bioventures Capital — 2018 Investments
3 investments dated 2018 · listed companies and verified rows first · show all
Profusa develops injectable hydrogel biosensors and AI-driven health platforms that enable real-time measurement of body chemistry from within tissue.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSan Francisco, US
Bill Fawcett(Co-founder)Natalie Wisniewski(Executive Officer, Director)inBill McMillan(Co-Founder, CSO & Head of Research)Ben Healy(CEO)Ben Hwang(Executive Officer, Director)inBen Hwang, Ph.D.(Chairman & CEO)in
Co-investorsAsset Management CompanyAtinum Investment Co. Ltd.Sand Hill AngelsBioVentures
BiotechSan Carlos, US
Xiaodong Yang(President, CEO and Secretary)inOvid Trifan(Executive Officer)Amy Wong(Executive Officer)Francis Sarena(Chief Operating Officer)Frank Hsu(Chief Medical Officer)William Duke, Jr.(Chief Financial Officer)
Co-investorsEFung CapitalShangBay Capital LLCDecheng CapitalSv Tech Ventures, Inc.Virtus Inspire Ventures
Biocytogen (HKEX: 02315) is a global biotechnology company that uses genetically engineered mouse models and its RenMice/RenMab/RenNano fully human antibody platforms to develop therapeutic antibody drugs.
BiotechDeep TechHealthtechBeijing, CN
Yuelei Shen(Founder)in
Co-investorsCowin Capital GroupOriza HoldingsSDIC Venture Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.